Rethinking of Small Molecules in Treating Psoriasis

Abstract

The author concerns that long-term application of biologics will destroy the natural balance, and argues to rethink about small molecules that can restore immune homeostasis, thereby naturally correcting overproduced proinflammatory cytokines, as a strategy of new drug development against psoriasis and other autoimmune disorders.